GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Link of Recording
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
GlaxoSmithKline Pharmaceuticals Limited has informed the stock exchanges (BSE and NSE) that a recording of analyst and institutional investor meetings has been uploaded to their investor relations portal. This disclosure is made under SEBI's Regulation 30 and Part A of Schedule III of the Listing Obligations and Disclosure Requirements Regulations, 2015. The company has provided a link to the audio/video file on their website. The filing is dated 13th May 2026 and signed by Ajay Nadkarni, Vice President - Administration, Real Estate & Company Secretary. The actual content of the analyst meeting recording is not included in this filing itself.
This is a routine regulatory disclosure informing investors that an analyst meeting recording is available for viewing. The filing itself does not contain specific details about discussions or new information, so it is unlikely to have an immediate impact on the stock price.